AdaptHealth to Elect Declassified Board, Details Executive Compensation with Strong Pay-for-Performance Alignment

summarizeSummary

AdaptHealth Corp. filed its definitive proxy statement for its annual meeting, proposing the election of a fully declassified board and detailing executive compensation, which includes significant annual bonuses and the forfeiture of prior performance-based equity awards due to underperformance.

check_boxKey Events

• Board Declassification Completed

  All nine directors will now be elected annually for one-year terms, enhancing corporate governance and accountability.

• Executive Compensation Aligned with Performance

  2025 annual cash bonuses for NEOs paid out at 116.22% of target, reflecting strong achievement of financial metrics (Net Revenue, Adjusted EBITDA, Free Cash Flow).

• Prior Performance Equity Forfeited

  Performance-vested stock units (PSUs) granted in 2022 and 2023 resulted in a 0% payout due to the company's Total Shareholder Return (TSR) falling below threshold relative to peers, underscoring a rigorous pay-for-performance model.

• Director Not Renominated

  Diana Nole's term will expire at the 2026 Annual Meeting as she was not renominated for election.

auto_awesomeAnalysis

The filing highlights key corporate governance enhancements, including the completion of board declassification, ensuring all directors will now serve one-year terms, which generally improves accountability. Executive compensation for 2025 shows a strong link between pay and performance, with annual cash bonuses for named executive officers (NEOs) paying out at 116.22% of target based on Net Revenue, Adjusted EBITDA, and Free Cash Flow. Crucially, performance-vested restricted stock units (PSUs) granted in 2022 and 2023 were forfeited (0% payout) due to the company's Total Shareholder Return (TSR) falling below threshold levels relative to peers. This demonstrates a robust pay-for-performance philosophy where long-term incentives are genuinely at risk and align with shareholder outcomes. Investors should note the company's commitment to these governance and compensation practices, especially in light of the previously reported net loss for 2025.